The Return of Hip Resurfacing?

A member of the JointMedica team was privileged to have attended the inaugural Pathways Conference, held in London on 4 October 2019. Details of this independent scientific meeting can be found at the following link.

This meeting coincided with the 50th anniversary of JRI Orthopaedics. Founded in 1969 by orthopaedic surgeon Ronald Furlong. It is acknowledged within the orthopaedic industry that JRI was the first company to offer a primary total hip replacement implant with Hydroxyapatite coating.

This event was chaired by Prof Justin Cobb, Chair of Orthopaedics and clinical lead at Imperial College, London. Prof Cobb also serves as a civilian advisor in orthopaedics to the Royal Air Force and is Orthopaedic Surgeon to Her Majesty the Queen.

As part of the program for this international event Prof Derek McMinn had been invited to talk specifically on the subject of Hip Resurfacing.

The title of his presentation being: The Return of Hip Resurfacing


Prof McMinn delivered a pre recorded presentation where he outlined and identified the key advantages Hip Resurfacing has to offer the surgical and patient community. He went on to identify new materials and clinical results gathered from a modest series of specific custom-made metal on Crosslink Polyethylene Hip Resurfacings, which we believe offer a viable alternative to Prof McMinn’s previous Birmingham Hip Resurfacing™ Metal-on-Metal design.


This new concept potentially allows a return of Hip Resurfacing in both male and female patients irrespective of implant size. These materials potentially increase the isoelastic component to bone interface, reducing stress shielding, and have the potential to eliminate the localised production of Metal Ions.

Examples of Jointmedica Custom made hip resurfacing components

The meetings international audience were questioned throughout the event via an interactive smartphone app which allowed real time feedback to questions posed by the assembly chairman.


The responses specific to the question of re-evaluating the use of Hip Resurfacing in clinical practice mirrored what we are observing at other key orthopaedic meetings. 

We feel the interest in Hip Resurfacing is once again growing within the orthopaedic community. 

The availability of new materials and advanced manufacturing techniques suggest new implants will be available to Specialist Hip Surgeons who will continue to offer Hip Resurfacing to suitable patients.

The following interview provides an insight into JointMedica's Hip Resurfacing journey to date.

Pathways Poll.png
Yes - 40.43%
Image taken during the Pathways meeting after Prof McMinn’s presentation and discussion, showing 40% of the surgeons in attendance would re consider Hip Resurfacing in their surgical practice.